Summary
- Current Price
- As of today, RNAC price is $9.73, down -1.52% in the most recent trading session on
- Current Price All-Time High
- RNAC price is currently -98.84% below its historical high of $840.00 set on
- Market Cap
- RNAC current market cap is $286M, up +10.23% over the past 365 days
- PE Ratio
- RNAC PE ratio is unknown
- Revenue
- RNAC current annual revenue is $2.80M, down -92.81% year-over-year
- Next Earnings
- The next earnings release for RNAC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cartesian Therapeutics, Inc. |
| Ticker | NASDAQ: RNAC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cartesiantherapeutics.com |
| Employees | 66 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $9.73 | ||
| Price, 1D Change | -1.52% | |
| $286M | ||
| - | ||
| - | ||
| 1.87 | ||
| $3M | ||
| Revenue, 1Y Change | -92.81% | |
| -$5.02 | ||
| EPS, 1Y Change | -11.95% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | SELB | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$5.02 | ||
| EPS Estimate | N/A | -$3.35 |
| EPS Est. Change | N/A | +33.22% |
| $2.80M | ||
| Revenue Estimate | N/A | $552.25K |
| Revenue Est. Change | N/A | -80.26% |
| $9.73 | ||
| Price Target | - | $39.00 |
| Price Tgt. Change | - | +300.82% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$4.48 | - | |
| -$1.93 | -$5.02 | -159.94% | |
| -$3.35 | N/A | +33.22% | |
| -$2.68 | N/A | +46.58% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $39.74M | $38.91M | -2.09% | |
| $1.97M | $2.80M | +42.20% | |
| $552.25K | N/A | -80.26% | |
| $401.50K | N/A | -85.65% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -2.70% | ||
| -72.51% | ||
| +10.23% | ||
| +57.91% | ||
| -92.81% | ||
| -97.48% | ||
| -11.95% | ||
| -268.27% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $9.73 | ||
| $7.70 | ||
| $7.13 | ||
| $8.27 | ||
| $7.31 | ||
| $0.52 | ||
| 1.87 | ||
| $1.04 | ||
| 66.49 | ||
| 153.07% | ||
| 88.23% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.80M | ||
| -$5.02 | ||
| $2.80M | ||
| -5.79% | ||
| -$86.71M | ||
| -3,099.93% | ||
| -$130.30M | ||
| -4,658.63% | ||
| -$83.75M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.10 | ||
| 8.65 | ||
| 8.65 | ||
| - | ||
| 2 | ||
| -3.97 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 161.06 | ||
| -1.93 | ||
| -2.01 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$126.24M | ||
| $125.14M | ||
| $296.41M | ||
| $129.28M | ||
| $422.65M | ||
| $14.94M | ||
| $12.68M | ||
| $4.15M | ||
| $1.29M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $133.10M | ||
| $89.50M | ||
| $2.96M | ||
| $0.00 | ||
| $2.96M | ||
| $0.00 | ||
| -$9.19M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$73.94M | ||
| -$5.45M | ||
| -$8.06M | ||
| $5.45M | ||
| -$79.40M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| Needham | → | |
| BTIG | → | |
| Wedbush | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| Wedbush | → | |
| Needham | → | |
| Cantor Fitzgerald | → |
Analyst sentiment
Institutional ownership
Screeners with RNAC
FAQ
What is the ticker symbol for Cartesian Therapeutics, Inc.?
The ticker symbol for Cartesian Therapeutics, Inc. is NASDAQ:RNAC
Does Cartesian Therapeutics, Inc. pay dividends?
No, Cartesian Therapeutics, Inc. does not pay dividends
What sector is Cartesian Therapeutics, Inc. in?
Cartesian Therapeutics, Inc. is in the Healthcare sector
What industry is Cartesian Therapeutics, Inc. in?
Cartesian Therapeutics, Inc. is in the Biotechnology industry
What country is Cartesian Therapeutics, Inc. based in?
Cartesian Therapeutics, Inc. is headquartered in United States
When did Cartesian Therapeutics, Inc. go public?
Cartesian Therapeutics, Inc. initial public offering (IPO) was on June 22, 2016
Is Cartesian Therapeutics, Inc. in the S&P 500?
No, Cartesian Therapeutics, Inc. is not included in the S&P 500 index
Is Cartesian Therapeutics, Inc. in the NASDAQ 100?
No, Cartesian Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Cartesian Therapeutics, Inc. in the Dow Jones?
No, Cartesian Therapeutics, Inc. is not included in the Dow Jones index
When was Cartesian Therapeutics, Inc. last earnings report?
Cartesian Therapeutics, Inc.'s most recent earnings report was on April 30, 2026
When does Cartesian Therapeutics, Inc. report earnings?
The next expected earnings date for Cartesian Therapeutics, Inc. is August 6, 2026
Data Sources & References
- RNAC Official Website www.cartesiantherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1453687/000145368726000064/0001453687-26-000064-index.htm
- RNAC Profile on Yahoo Finance finance.yahoo.com/quote/RNAC
- RNAC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rnac